1975
DOI: 10.1515/bchm2.1975.356.2.1565
|View full text |Cite
|
Sign up to set email alerts
|

In-vivo-Untersuchungen zur Metabolisierung der Pyrimidinnucleoside

Abstract: Zusammenfassung: Nach Applikation von [5 -3 H]Uridin wurden in der Perchlorsäure-lös-lichen Fraktion von Blutplasma und Leber adulter männlicher Wistar-Ratten die 3 H-Metabolite ermittelt. 10 min nach Uridininjektion beträgt der Anteil des [ 3 H]Uridins an der gesamten 3 HAktivität des Blutplasmas nur noch 20%. Die üb-rige Radioaktivität verteilt sich hauptsächlich auf [ 3 H]Uracil (40%) und auf 3 H 2 0 (20%). In der Leber ist zu diesem Zeitpunkt die Summe der [ 3 H]Uridin-und [ 3 H]Uracü-Aktivität kleiner als… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1978
1978
2012
2012

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…Hepatocytes possess the complete pathway for the conversion of uridine into the end-products of pyrimidine catabolism, which has not been detected in nonparenchymal liver cells (31) or other tissues except for the kidneys (26, 40). The rate of hepatic nucleotide formation from extracellular uridine is almost negligible as compared with the rate of its catabolism in hepatocytes (31,36,37,41), the isolated-perfused rat liver (27, 28) and in the liver in uiuo (8,(23)(24)(25)(26). Under the conditions of our perfusion experiments, the rate of uridine uptake (i.e., transport and metabolism) was nearly identical to the rate of uridine catabolite formation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hepatocytes possess the complete pathway for the conversion of uridine into the end-products of pyrimidine catabolism, which has not been detected in nonparenchymal liver cells (31) or other tissues except for the kidneys (26, 40). The rate of hepatic nucleotide formation from extracellular uridine is almost negligible as compared with the rate of its catabolism in hepatocytes (31,36,37,41), the isolated-perfused rat liver (27, 28) and in the liver in uiuo (8,(23)(24)(25)(26). Under the conditions of our perfusion experiments, the rate of uridine uptake (i.e., transport and metabolism) was nearly identical to the rate of uridine catabolite formation.…”
Section: Discussionmentioning
confidence: 99%
“…The liver plays an important role in systemic pyrimidine catabolism under in uiuo conditions (23)(24)(25)(26) and eliminates in a single passage most of the uridine (27,281 and adenosine (29,30) in portal vein blood. A rapid permeation of adenosine and uridine across the cell membrane is a prerequisite for their efficient clearance from the sinusoidal blood by nonparenchymal and parenchymal liver cells (30,31).…”
mentioning
confidence: 99%
“…Although a higher labelling efficiency can be obtained using orotate [45], this precursor is taken up much more slowly and its half-life in the body of several hours [45-481 would be a substantial fraction of the total experimental period. The half-life of uridine in blood, however, is only 9 min [49] and, therefore, better suited for pulse-labelling.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, more than 90% of the circulating uridine is catabolized in a single pass through the liver by the activity of hepatic uridine phosphorylase (UP, EC 2.4.2.3), while constant amounts of uridine are synthesized de novo and released into the hepatic vein blood [28,29]. Less than 2% of the uridine metabolized by the liver is salvaged and recovered in the uracil nucleotide pool in tissues of whole animals [27,[30][31][32], perfused rat liver [6,13], or isolated liver cells [31]. The remainder is rapidly catabolized to products beyond uracil in the pyrimidine catabolic pathway [13,28,33].…”
Section: Introductionmentioning
confidence: 99%